Sage Journals: Discover world-class research

Abstract

Purpose

Nitric oxide (NO) is a potential marker in the diagnosis and monitoring of treatment for the management of patients with allergic rhinitis (AR). The study aimed to determine the value of nasal fractional exhaled nitric oxide (FeNO) in the diagnosis and treatment response of AR patients.

Methods

The participants were divided into control and allergic rhinitis groups based on the clinical symptoms and skin prick tests. The AR group was treated with intranasal corticosteroid after the diagnosis. The nasal fractional exhaled nitric oxide (FENO) levels were compared between control and AR groups. In the AR group, the visual analogue scale (VAS), Nasal Obstruction Symptoms Evaluation (NOSE) questionnaire, and nasal fractional exhaled nitric oxide (FeNO) were assessed pre- and post-treatment.

Results

One hundred ten adults were enrolled. The nasal FeNO level was significantly higher in AR compared to control (p < 0.001). Both the subjective (VAS and NOSE), both (p < 0.01) and objective (nasal FeNO, p < 0.001) assessments showed significant different pre- and post-treatment. The threshold level of nasal FeNO in the diagnosis of AR was 390.0 ppb (sensitivity of 73% and specificity of 80%) based on the receiver operator characteristic curve.

Conclusion

Nasal FeNO level is significantly higher in AR compared to control group with significant difference pre- and post-treatment. The findings suggest nasal FeNO can serve as an adjunct diagnostic tool together with the monitoring of treatment response in AR.

Keywords

nitric oxide adult fractional exhaled nitric oxide testing breath test allergic rhinitis perennial nasal obstruction visual analogue scale control group questionnaires

Get full access to this article

View all access options for this article.

References

Corbelli

Bringolf-Isler

Amacher

, et al. Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia. Chest. 2004 Oct;126(4):1054–1059. doi: 10.1378/chest.126.4.1054. PMID: 15486363.

Chong

Chew

. Epidemiology of allergic rhinitis and associated risk factors in Asia. World Allergy Organ J. 2018;11(1):17. doi: 10.1186/s40413-018-0198-z.

Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med. 1995 Apr;1(4):370–373.

Conboy PJ, Jones NS. The nose and nitric oxide: A review. Clin Otolaryngol. 2000 Oct;25(5):337–341.

Runer

Cervin

Lindberg

, et al. Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg. 1998;119(3):278–287. doi:10.1016/S0194-5998(98)70063-4

Kim

J-W

Min

Y-G

Rhee

C-S

, et al. Regulation of mucociliary motility by nitric oxide and expression of nitric oxide synthase in the human Sinus epithelial cells. Laryngoscope. 2001;111(2):246–250. doi:10.1097/00005537-200102000-00011.

Kawamoto H, Takeno S, Yajin K. Increased expression of inducible nitric oxide synthase in nasal epithelial cells in patients with allergic rhinitis. The Laryngoscope. 1999 Dec;109(12):2015–2020.

Scadding

. Update on the use of nitric oxide as a noninvasive measure of airways inflammation. Rhinology. 2009;47(2):115–120. PMID: 19593964.

Nakano

Ide

Imada

, et al. Reduced nasal nitric oxide in diffuse panbronchiolitis. Am J Respir Crit Care Med. 2000;162(6):2218–2220. doi: 10.1164/ajrccm.162.6.2003051.

10.

Smith AD, Cowan JO, Brassett KP, et al. Exhaled nitric oxide: A predictor of steroid response. Am J Respir Crit Care Med. 2005 Aug 15;172(4):453–459.

11.

Stewart

Witsell

Smith

, et al. Development and validation of the nasal obstruction symptom evaluation (NOSE) scale. Otolaryngol Head Neck Surg. 2004;130(2):157–163.

12.

Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007 Apr;62(4):367–372.

13.

Jones

Herbison

Cowan

, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: Dose-response relationship. Eur Respir J. 2002;20(3):601–608. DOI: 10.1183/09031936.02.00285302.

14.

Ren

Zhang

. Nasal nitric oxide is correlated with nasal patency and nasal symptoms. Allergy Asthma Immunol Res. 2019;11(3):367–380. doi:10.4168/aair.2019.11.3.367.

15.

Maniscalco

Sofia

Pelaia

. Nitric oxide in upper airways inflammatory diseases. Inflamm. res. 2007;56(2):58–69. doi:10.1007/s00011-006-6111-1.

16.

Vural

Gungor

. Variations of nasal nitric oxide in a subject with allergic rhinitis: A longitudinal study. Am J Otolaryngol. 2002;23(4):191–195. doi:10.1053/ajot.2002.123438.

17.

Kharitonov SA, Rajakulasingam K, O'Connor B, et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol. 1997 Jan 1;99(1):58–64.

18.

Chen

Takeno

Osada

, et al. Modulation of ciliary activity by tumor necrosis factor-alpha in cultured sinus epithelial cells. Possible roles of nitric oxide. Hiroshima J Med Sci. 2000;49(1):49–55. PMID: 10824457.

19.

Kim JH, Park JS, Moon SH, Lim DH, Hwang SY. Exhaled nitric oxide and symptom severity in children with allergic rhinitis. J Allergy Ther. 2017;8(268):2. doi:10.4172/2155-6121.1000268.

20.

Redington AE, Meng QH, Springall DR, et al. Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax. 2001 May 1;56(5):351–357.

21.

Nesic

Djordjevic

Tomic-Spiric

, et al. Measuring nasal nitric oxide in allergic rhinitis patients. J Laryngol Otol. 2016;130(11):1064–1071. PMID: 27823578. DOI: 10.1017/S0022215116009087.

22.

Wen

Lin

Yang

, et al. Nasal nitric oxide is a useful biomarker for acute unilateral maxillary sinusitis in pediatric allergic rhinitis: A prospective observational cohort study. World Allergy Organ J. 2019;12(4):100027.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

Diagnostic Value and Clinical Application of Nasal Fractional Exhaled Nitric Oxide in Subjects with Allergic Rhinitis